CRP and depressive symptom measurement: Similar divergent MR results have also been reported for schizophrenia and depression, suggesting a protective effect of CRP and a risk-increasing effect of soluble IL-6 receptor (IL-6R) on schizophrenia and depression risk, respectively [45, 46].